QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity

被引:10
|
作者
Garcia, Mariana L. [1 ]
de Oliveira, Andrew A. [1 ]
Bueno, Renata, V [1 ]
Nogueira, Victor H. R. [1 ]
de Souza, Guilherme E. [1 ]
Guido, Rafael V. C. [1 ]
机构
[1] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
malaria; N-myristoyltransferase; QSAR; EFFICIENT GENERATION; ELECTROSTATIC POTENTIALS; ANALYSIS COMSIA; ORBITAL METHODS; FIELD ANALYSIS; AM1-BCC MODEL; PREDICTION; DISCOVERY; 3D-QSAR; DESIGN;
D O I
10.1002/ddr.21646
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Malaria is an infectious disease caused by protozoan parasites of the genus Plasmodium and transmitted by Anopheles spp. mosquitos. Due to the emerging resistance to currently available drugs, great efforts must be invested in discovering new molecular targets and drugs. N-myristoyltransferase (NMT) is an essential enzyme to parasites and has been validated as a chemically tractable target for the discovery of new drug candidates against malaria. In this work, 2D and 3D quantitative structure-activity relationship (QSAR) studies were conducted on a series of benzothiophene derivatives as P. falciparum NMT (PfNMT) and human NMT (HsNMT) inhibitors to shed light on the molecular requirements for inhibitor affinity and selectivity. A combination of Quantitative Structure-activity Relationship (QSAR) methods, including the hologram quantitative structure-activity relationship (HQSAR), comparative molecular field analysis (CoMFA), and comparative molecular similarity index analysis (CoMSIA) models, were used, and the impacts of the molecular alignment strategies (maximum common substructure and flexible ligand alignment) and atomic partial charge methods (Gasteiger-Huckel, MMFF94, AM1-BCC, CHELPG, and Mulliken) on the quality and reliability of the models were assessed. The best models exhibited internal consistency and could reasonably predict the inhibitory activity against both PfNMT (HQSAR: q(2)/r(2)/r(pred)(2) = 0.83/0.98/0.81; CoMFA: q(2)/r(2)/r(pred)(2) = 0.78/0.97/0.86; CoMSIA: q(2)/r(2)/r(pred)(2) = 0.74/0.95/0.82) and HsNMT (HQSAR: q(2)/r(2)/r(pred)(2) = 0.79/0.93/0.74; CoMFA: q(2)/r(2)/r(pred)(2) = 0.82/0.98/0.60; CoMSIA: q(2)/r(2)/r(pred)(2) = 0.62/0.95/0.56). The results enabled the identification of the polar interactions (electrostatic and hydrogen-bonding properties) as the major molecular features that affected the inhibitory activity and selectivity. These findings should be useful for the design of PfNMT inhibitors with high affinities and selectivities as antimalarial lead candidates.
引用
收藏
页码:264 / 284
页数:21
相关论文
共 50 条
  • [1] Characterization of N-myristoyltransferase from Plasmodium falciparum
    Gunaratne, RS
    Sajid, M
    Ling, IT
    Tripathi, R
    Pachebat, JA
    Holder, AA
    BIOCHEMICAL JOURNAL, 2000, 348 : 459 - 463
  • [2] Characterization of N-myristoyltransferase from Plasmodium falciparum
    Gunaratne, Ruwani S.
    Sajid, Mohammed
    Ling, Irene T.
    Tripathi, Renu
    Pachebat, Justin A.
    Holder, Anthony A.
    Biochemical Journal, 2000, 348 (02) : 459 - 463
  • [3] Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase
    Yu, Zhiyong
    Brannigan, James A.
    Rangachari, Kaveri
    Heal, William P.
    Wilkinson, Anthony J.
    Holder, Anthony A.
    Leatherbarrow, Robin J.
    Tate, Edward W.
    MEDCHEMCOMM, 2015, 6 (10) : 1767 - 1772
  • [4] 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors
    Sheng, Chunquan
    Zhu, Jie
    Zhang, Wannian
    Zhang, Min
    Ji, Haitao
    Song, Yunlong
    Xu, Hui
    Yao, Jianzhong
    Miao, Zhenyuan
    Zhou, Youjun
    Zhu, Ju
    Lu, Jiaguo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (04) : 477 - 486
  • [5] Discovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivax N-Myristoyltransferase
    Rackham, Mark D.
    Brannigan, James A.
    Moss, David K.
    Yu, Zhiyong
    Wilkinson, Anthony J.
    Holder, Anthony A.
    Tate, Edward W.
    Leatherbarrow, Robin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (01) : 371 - 375
  • [6] QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
    Santos-Garcia, Leticia
    de Mecenas Filho, Marco Antonio
    Musilek, Kamil
    Kuca, Kamil
    Ramalho, Teodorico Castro
    Ferreira da Cunha, Elaine Fontes
    MOLECULES, 2018, 23 (09):
  • [7] QSAR analysis of N-myristoyltransferase inhibitors: antifungal activity of benzofurans
    Hemantkumar S. Deokar
    Purushottamachar Puranik
    Vithal M. Kulkarni
    Medicinal Chemistry Research, 2009, 18 : 206 - 220
  • [8] Design and Synthesis of Inhibitors of Plasmodium falciparum N-Myristoyltransferase, A Promising Target for Antimalarial Drug Discovery
    Yu, Zhiyong
    Brannigan, James A.
    Moss, David K.
    Brzozowski, A. Marek
    Wilkinson, Anthony J.
    Holder, Anthony A.
    Tate, Edward W.
    Leatherbarrow, Robin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8879 - 8890
  • [9] QSAR analysis of N-myristoyltransferase inhibitors: antifungal activity of benzofurans
    Deokar, Hemantkumar S.
    Puranik, Purushottamachar
    Kulkarni, Vithal M.
    MEDICINAL CHEMISTRY RESEARCH, 2009, 18 (03) : 206 - 220
  • [10] Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase
    Rackham, Mark D.
    Yu, Zhiyong
    Brannigan, James A.
    Heal, William P.
    Paape, Daniel
    Barker, K. Victoria
    Wilkinson, Anthony J.
    Smith, Deborah F.
    Leatherbarrow, Robin J.
    Tate, Edward W.
    MEDCHEMCOMM, 2015, 6 (10) : 1761 - 1766